IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Now Playing

    How the rise of GLP-1 weight loss drug could boost the U.S. Economy

    02:45

  • UP NEXT

    Start TODAY: Get the September 2024 walking and core goals

    05:11

  • D-I-Why?? Dental experts warn against do-it-yourself braces

    03:03

  • FDA authorizes newest version of COVID vaccine

    00:24

  • Report finds health violations at Boar’s Head plant linked to listeria outbreak

    02:30

  • Tennessee teen collapses and dies while jogging in extreme heat

    01:26

  • Officials stress safety following 2 more deaths linked to West Nile

    02:11

  • Growing concern over West Nile virus after teen is paralyzed

    01:49

  • Catching up on weekend sleep may decrease heart disease

    00:36

  • How to be your own best health advocate

    05:13

  • Fears grow over mosquito-borne illnesses after teen left paralyzed

    02:42

  • CDC says nine deaths from listeria tied to tainted deli meats

    01:43

  • Is autoimmune disease tied to trauma? Doctor shares insight

    03:59

  • Gen Z boys are chewing ‘facial fitness’ gum for their jawlines

    03:31

  • Healthy 41-year-old dies from mosquito-borne virus

    01:45

  • Growing concern amid spread of mosquito-borne viruses

    01:30

  • Eli Lilly reduces price of weight loss drug for some patients

    02:26

  • Inside the pharmacies creating ‘copycat’ versions of weight-loss drugs

    05:41

  • Understanding a non-verbal learning disorder

    04:08

  • Eli Lilly slashes prices of low doses of weight loss drug by scrapping auto-injector

    02:30

Leo Feler, chief economist and numerator, speaks with NBC News’ Christine Romans on his ongoing research on the economic benefits of the rise of GLP-1 weight-loss drug usage in America.